cord blood-derived mesenchymal stem cell therapy (EndGenitor)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namecord blood-derived mesenchymal stem cell therapy (EndGenitor)
Drug Alias Nameadult stem cell therapy (EndGenitor)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEndGenitor Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndGenitor Technologies Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A